Hello all hope you can help.
I am interested in a Columbian Muzo Green Emerald ring which had been tested by GRS in 2023. However I dont understand the small prints underneath the treatment result. I looked in the GRS website and to my understanding that potential post-testing treatment would be mentioned in the report anyway since 2022.
What i dont understand is 'minor non-enhanced clarity features are eye visible' does that mean the stone might not be necessarily 'insignificant ' if those non-enhaced festures got treated? Would this comment affect the price in long term please? I like to get this as an investment but now not too sure. Many thanks in advance.

I am interested in a Columbian Muzo Green Emerald ring which had been tested by GRS in 2023. However I dont understand the small prints underneath the treatment result. I looked in the GRS website and to my understanding that potential post-testing treatment would be mentioned in the report anyway since 2022.
What i dont understand is 'minor non-enhanced clarity features are eye visible' does that mean the stone might not be necessarily 'insignificant ' if those non-enhaced festures got treated? Would this comment affect the price in long term please? I like to get this as an investment but now not too sure. Many thanks in advance.
